The PROTAC molecule performed better than inhibitor in the downstream signaling pathways of FAK (p-FAK, p-Paxillian, p-Akt) and in the invasion and migration of human triple-negative breast cancer cell (MDA-MB-231). The gene discussed is PTK2; the disease is triple-negative breast carcinoma.